Skip to main content
MGPI
NASDAQ Trade & Services

MGP Ingredients Reports Massive Q1 Net Loss of $134.8M Driven by $179.5M Impairment Charges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
9
Price
$20.21
Mkt Cap
$431.87M
52W Low
$16.45
52W High
$34.985
52W Position info
23% above low
Off High info
42% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

MGPI sits 23% above its 52-week low of $16.45.

Summary

MGP Ingredients reported a Q1 2026 net loss of $134.8 million, or $(6.30) per share, primarily due to $179.5 million in non-cash impairment charges, alongside a 13% decline in consolidated sales.


Key Events · Earnings and Guidance · MGPI

  • Massive Net Loss Reported

    The company reported a net loss of $134.8 million, or $(6.30) per share, for Q1 2026, a significant decline from a $(0.14) loss per share in the prior year.

  • Substantial Impairment Charges

    Results were heavily impacted by $179.5 million in non-cash impairment adjustments to goodwill and other long-lived assets, plus a $26.9 million fixed asset impairment at its Lux Row distillery.

  • Continued Sales Decline

    Consolidated sales decreased 13% to $106.4 million, driven by expected declines in brown goods sales in the Distilling Solutions segment.

  • Full-Year Guidance Reaffirmed

    Despite the Q1 performance, MGP Ingredients reaffirmed its full-year 2026 guidance for sales, adjusted EBITDA, and adjusted basic EPS.


Analysis · MGPI · Trade & Services

MGP Ingredients reported a substantial net loss of $134.8 million, or $(6.30) per share, for the first quarter of 2026. This significant loss was primarily due to non-cash impairment adjustments totaling $179.5 million for goodwill and other long-lived assets in the Branded Spirits segment, along with a $26.9 million impairment related to equipment at its Lux Row distillery. These charges follow a $152.6 million goodwill impairment reported in the prior fiscal year, indicating ongoing challenges in asset valuation and market conditions. Consolidated sales also decreased by 13% to $106.4 million, continuing a negative trend. While the company reaffirmed its full-year 2026 guidance, the magnitude of the Q1 loss and impairment charges, which represent a significant portion of the company's market capitalization, signals severe financial headwinds and raises concerns about the company's underlying asset values and operational performance.

At the time of this filing, MGPI was trading at $20.21 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $431.9M. The 52-week trading range was $16.45 to $34.99. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGPI - Latest Insights

MGPI
Apr 29, 2026, 7:33 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $20.21
Real-time Price: $17.69 info
Change: -$2.52 (-12%) info
Market Cap: $378.057M info
MGPI
Apr 29, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $20.21
Real-time Price: $17.69 info
Change: -$2.52 (-12%) info
Market Cap: $378.057M info
MGPI
Apr 09, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $18.91
Real-time Price: $17.69 info
Change: -$1.22 (-6%) info
Market Cap: $378.057M info
MGPI
Apr 07, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.07
Real-time Price: $17.69 info
Change: -$1.38 (-7%) info
Market Cap: $378.057M info
MGPI
Apr 07, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.07
Real-time Price: $17.69 info
Change: -$1.38 (-7%) info
Market Cap: $378.057M info